Charles W Newhall Iii Supernus Pharmaceuticals, Inc. (SUPN) insider trading activity

SUPN Quotes by TradingView

Charles W Newhall Iii is Director of SUPERNUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 120,975 shares of SUPN, which is worth approximately $3.89 Million. The most recent transaction as insider was on Feb 23, 2024, when has been sold 3,886 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 121K
0% 3M change
7.89% 12M change
Total Value Held $3.89 Million

CHARLES W NEWHALL III Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 23 2024
BUY
Grant, award, or other acquisition
-
3,886 Added 3.11%
120,975 Common Stock
Nov 16 2023
SELL
Open market or private sale
$70,025 $28.01 p/Share
2,500 Reduced 2.09%
117,089 Common Stock
Nov 16 2023
BUY
Exercise of conversion of derivative security
$68,902 $9.24 p/Share
7,457 Added 5.87%
119,589 Common Stock
Feb 22 2023
BUY
Grant, award, or other acquisition
-
3,882 Added 3.35%
112,132 Common Stock
Dec 28 2022
BUY
Exercise of conversion of derivative security
$68,903 $7.9 p/Share
8,722 Added 7.32%
110,453 Common Stock
Feb 19 2022
BUY
Grant, award, or other acquisition
-
4,222 Added 3.98%
101,731 Common Stock
CWN

Charles W Newhall Iii

Director
Rockville, MD

Track Institutional and Insider Activities on SUPN

Follow SUPERNUS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SUPN shares.

Notify only if

Insider Trading

Get notified when an Supernus Pharmaceuticals, Inc. insider buys or sells SUPN shares.

Notify only if

News

Receive news related to SUPERNUS PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SUPN